FFIV vs HALO · P/E 32, rev $3.09B vs P/E 15, rev $857.7M
F5 Networks Inc (FFIV) versus Halozyme Therapeutics Inc (HALO) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Not investment advice. Open the FFIV and HALO stock pages for the full models.
Not investment advice.